Dolby Laboratories Stock Plummets to New 52-Week Low at $64.38

Dolby Laboratories, Inc. has reached a new 52-week low, trading at USD 64.38 as of November 7, 2025. This marks a significant decline for the small-cap software company, which has seen its stock price decrease by 17.7% over the past year, contrasting sharply with the S&P 500's performance of 12.65% during the same period.
The company's market capitalization stands at USD 7,024 million, with a price-to-earnings (P/E) ratio of 27.00. Despite a dividend yield of 1.80%, Dolby's financial metrics indicate a challenging environment. The return on equity is reported at 10.42%, while the price-to-book ratio is 2.70, suggesting that the stock is trading at a premium compared to historical valuations of its peers.

Recent quarterly results have shown a decline in pre-tax profit by 33.05% and net profit by 31.39%. Additionally, the company has experienced flat sales growth, with net sales increasing at an annual rate of just 2.52% over the last five years. With high institutional holdings at 100%, these investors have increased their stake by 1.89% in the previous quarter, reflecting a continued interest in the company's fundamentals despite recent performance challenges.